New Holter monitor nets FDA OK from Cardiac Science

Dave Pearson | January 10, 2012 | Health Exec | Digital Transformation

Opto Circuits of Bengaluru, India, has earned FDA approval to sell a new Holter monitor through its American subsidiary, Cardiac Science of Bothell, Wash.

The device, MySense Heart, is lightweight and portable, according to Cardiac Science, adding that the company intends to leverage the market approval to bring other new products to market.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Cardiovascular Business

Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals.

AI in Healthcare

A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business

FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

New Holter monitor nets FDA OK from Cardiac Science

Related Content

Around the web